Data as of Dec 11
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Chelsea Therapeutics International Ltd have a median target of 4.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +10.50% increase from the last price of 3.62.
The current consensus among 4 polled investment analysts is to Buy stock in Chelsea Therapeutics International Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.